Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium

Annals of Surgical Oncology

Volumn 26, Issue 6, 2019, Pages 1814-1823

  Lopez Aguiar, Alexandra G ^a   Ethun, Cecilia G ^a   Pawlik, Timothy M ^b,i   Tran, Thuy ^c   Poultsides, George A ^c   Isom, Chelsea A ^d   Idrees, Kamran ^d   Krasnick, Bradley A ^e   Fields, Ryan C ^e   Salem, Ahmed ^f   Weber, Sharon M ^f   Martin, Robert C G ^g   Scoggins, Charles R ^g   Shen, Perry ^h   Mogal, Harveshp D ^h   Beal, Eliza W ⁱ   Schmidt, Carl ⁱ   Shenoy, Rivfka ^j   Hatzaras, Ioannis ^j   Maithel, Shishir K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g University of Louisville School of Medicine   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j NEW YORK UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BILE DUCT CANCER; BILE DUCT CARCINOMA; BLOOD TRANSFUSION; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PANCREATICODUODENECTOMY; PATHOLOGY; PERIOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; BILE DUCT NEOPLASMS; BLOOD TRANSFUSION; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PANCREATICODUODENECTOMY; PERIOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 85063029450     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-019-07306-x     Document Type: Article

References (33)

1. Dickson PV, Behrman SW. Distal cholangiocarcinoma. Surg Clin North Am. 2014;94(2):325–42.
2. Ethun CG, Lopez-Aguiar AG, Pawlik TM, et al. Distal cholan-giocarcinoma and pancreas adenocarcinoma: are they really the same disease? A 13-institution study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium. J Am Coll Surg. 2017;224(4):406–13.
3. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholan-giocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755–62.
4. Riall TS, Cameron JL, Lillemoe KD, et al. Resected peri-ampullary adenocarcinoma: 5-year survivors and their 6-to 10-year follow-up. Surgery. 2006;140(5):764–72.
5. Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17(4):991–97.
6. Cameron JL, He J. Two thousand consecutive pancreaticoduo-denectomies. J Am Coll Surg. 2015;220(4):530–36.
7. Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagi-sawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010;97(9):1363–8.
8. Kiriyama M, Ebata T, Aoba T, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg. 2015;102(4):399–406.
9. Murakami Y, Uemura K, Hayashidani Y, et al. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol. 2007;95(3):207–12.
10. Squires MH, 3rd, Kooby DA, Poultsides GA, et al. Effect of perioperative transfusion on recurrence and survival after gastric cancer resection: a 7-institution analysis of 765 patients from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221(3):767–77.
11. Postlewait LM, Squires MH, Kooby DA,Weber SM, Scoggins CR, Cardona K, Cho CS, Martin RCG, Winslow ER, Maithel SK. The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study of 456 patients. HPB. 2015;1–8.
12. Kneuertz PJ, Patel SH, Chu CK, et al. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma. Ann Surg Oncol. 2011;18(5):1327–34.
13. Poorman CE, Postlewait LM, Ethun CG, et al. Blood transfusion and survival for resected adrenocortical carcinoma: a study from the United States Adrenocortical Carcinoma Group. Am Surg. 2017;83(7):761–68.
14. Sutton JM, Kooby DA, Wilson GC, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocar-cinoma: a multi-institutional study. J Gastrointest Surg. 2014;18(9):1575–87.
15. Gierth M, Aziz A, Fritsche HM, et al. The effect of intra-and postoperative allogenic blood transfusion on patients’ survival undergoing radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2014;32(6):1447–53.
16. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006;(1):CD005033.
17. Keller SM, Groshen S, Kaiser LR. Blood transfusion and lung cancer recurrence. Ann Thorac Surg. 1989;48(5):746–47.
18. Manyonda IT, Shaw DE, Foulkes A, Osborn DE. Renal cell carcinoma: blood transfusion and survival. Br Med J (Clin Res Ed). 1986;293(6546):537–38.
19. Linder BJ, Thompson RH, Leibovich BC, et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int. 2014;114(3):368–74.
20. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–74.
21. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
22. Wang T, Luo L, Huang H, et al. Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. Ann Thorac Surg. 2014;97(5):1827–37.
23. Perisanidis C, Dettke M, Papadogeorgakis N, et al. Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. Oral Oncol. 2012;48(4):372–78.
24. Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol). 2006;18(1):60–66.
25. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998;133(4):383–89.
26. Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 1999;25(3):231–43.
27. Pandey P, Chaudhary R, Aggarwal A, Kumar R, Khetan D, Verma A. Transfusion-associated immunomodulation: Quantitative changes in cytokines as a measure of immune responsiveness after one time blood transfusion in neurosurgery patients. Asian J Transfus Sci. 2010;4(2):78–85.
28. Innerhofer P, Tilz G, Fuchs D, et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis. Transfusion. 2000;40(7):821–27.
29. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–17.
30. Gani F, Cerullo M, Ejaz A, et al. Implementation of a blood management program at a tertiary care hospital: effect on transfusion practices and clinical outcomes among patients undergoing surgery. Ann Surg. 2017.
31. Shehata N, Whitlock R, Fergusson DA, et al. Transfusion Requirements in Cardiac Surgery III (TRICS III): study design of a randomized controlled trial. J Cardiothorac Vasc Anesth. 2018;32(1):121–29.
32. Jarnagin WR, Gonen M, Maithel SK, et al. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg. 2008;248(3):360–69.
33. Hallet J, Hanif A, Callum J, et al. The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: a systematic review and meta-analysis. Transfus Med Rev. 2014;28(4):205–11.